Tags

Type your tag names separated by a space and hit enter

Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg.
Case Rep Ophthalmol. 2012 Jan; 3(1):30-4.CR

Abstract

We report the case of a 62-year-old woman with a history of vitreoretinal surgery for vitreous hemorrhage secondary to central retinal vein occlusion (CRVO). Because of the persistence of macular edema (ME), she received 2 intravitreal injections of bevacizumab 0.5 mg (Avastin®, Genentech/Roche) three months after vitrectomy, without functional or anatomical improvement. Six months after vitrectomy, she therefore received an intravitreal implant of dexamethasone 0.7 mg (Ozurdex®). An improvement in her best-corrected visual acuity and central macular thickness, as measured by optical coherence tomography, was detected 7 days after the injection, and complete resolution of the ME and retinal hemorrhages was observed 6 months after the injection. Dexamethasone intravitreal implant might be an effective treatment option in ME secondary to CRVO, also in vitrectomized eyes.

Authors+Show Affiliations

Department of Ophthalmology, University of Catania, Catania, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports

Language

eng

PubMed ID

22615698

Citation

Reibaldi, Michele, et al. "Resolution of Persistent Cystoid Macular Edema Due to Central Retinal Vein Occlusion in a Vitrectomized Eye Following Intravitreal Implant of Dexamethasone 0.7 Mg." Case Reports in Ophthalmology, vol. 3, no. 1, 2012, pp. 30-4.
Reibaldi M, Russo A, Zagari M, et al. Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg. Case Rep Ophthalmol. 2012;3(1):30-4.
Reibaldi, M., Russo, A., Zagari, M., Toro, M., Grande De, V., Cifalinò, V., Rametta, S., Faro, S., & Longo, A. (2012). Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg. Case Reports in Ophthalmology, 3(1), 30-4. https://doi.org/10.1159/000336273
Reibaldi M, et al. Resolution of Persistent Cystoid Macular Edema Due to Central Retinal Vein Occlusion in a Vitrectomized Eye Following Intravitreal Implant of Dexamethasone 0.7 Mg. Case Rep Ophthalmol. 2012;3(1):30-4. PubMed PMID: 22615698.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg. AU - Reibaldi,Michele, AU - Russo,Andrea, AU - Zagari,Marco, AU - Toro,Mario, AU - Grande De,Vittorio, AU - Cifalinò,Valentina, AU - Rametta,Stefania, AU - Faro,Salvatore, AU - Longo,Antonio, Y1 - 2012/01/31/ PY - 2012/5/23/entrez PY - 2012/5/23/pubmed PY - 2012/5/23/medline KW - Central retinal vein occlusion KW - Cystoid macular edema KW - Dexamethasone 0.7 mg KW - Ozurdex® KW - Vitrectomized eye SP - 30 EP - 4 JF - Case reports in ophthalmology JO - Case Rep Ophthalmol VL - 3 IS - 1 N2 - We report the case of a 62-year-old woman with a history of vitreoretinal surgery for vitreous hemorrhage secondary to central retinal vein occlusion (CRVO). Because of the persistence of macular edema (ME), she received 2 intravitreal injections of bevacizumab 0.5 mg (Avastin®, Genentech/Roche) three months after vitrectomy, without functional or anatomical improvement. Six months after vitrectomy, she therefore received an intravitreal implant of dexamethasone 0.7 mg (Ozurdex®). An improvement in her best-corrected visual acuity and central macular thickness, as measured by optical coherence tomography, was detected 7 days after the injection, and complete resolution of the ME and retinal hemorrhages was observed 6 months after the injection. Dexamethasone intravitreal implant might be an effective treatment option in ME secondary to CRVO, also in vitrectomized eyes. SN - 1663-2699 UR - https://www.unboundmedicine.com/medline/citation/22615698/Resolution_of_Persistent_Cystoid_Macular_Edema_due_to_Central_Retinal_Vein_Occlusion_in_a_Vitrectomized_Eye_following_Intravitreal_Implant_of_Dexamethasone_0_7_mg_ L2 - https://www.karger.com?DOI=10.1159/000336273 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.